Biohaven Stock Guidance | NYSE:BHVN | Benzinga

Biohaven issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.

Get Alert
10/05/2021BHVN
Biohaven Pharma Hldgs
Q32021———$136.00M$136.00M$123.69MGet Alert
04/07/2021BHVN
Biohaven Pharma Hldgs
Q12021———$43.80M$43.80M$36.41MGet Alert
01/25/2021BHVN
Biohaven Pharmaceutical
Q42020———$35.00M$35.00M$25.31MGet Alert

FAQ

Q

What is the most recent guidance for Biohaven (BHVN)?

A

There have been no specific sales or earnings guidance reported for Biohaven in recent months.

Browse guidance and forecast on all stocks.

People Also Watch